Nipro Management
Management criteria checks 2/4
Nipro's CEO is Yoshihiko Sano, appointed in May 2012, has a tenure of 12.58 years. directly owns 0.068% of the company’s shares, worth ¥162.00M. The average tenure of the management team and the board of directors is 10.7 years and 15.5 years respectively.
Key information
Yoshihiko Sano
Chief executive officer
n/a
Total compensation
| CEO salary percentage | n/a |
| CEO tenure | 12.6yrs |
| CEO ownership | 0.07% |
| Management average tenure | 10.7yrs |
| Board average tenure | 15.5yrs |
Recent management updates
Recent updates
Nipro (TSE:8086) Will Pay A Larger Dividend Than Last Year At ¥20.00
Dec 10
Some May Be Optimistic About Nipro's (TSE:8086) Earnings
Nov 15Market Participants Recognise Nipro Corporation's (TSE:8086) Earnings
Oct 16These 4 Measures Indicate That Nipro (TSE:8086) Is Using Debt In A Risky Way
Sep 28Nipro's (TSE:8086) Dividend Will Be ¥12.00
Aug 30Nipro (TSE:8086) Has Announced A Dividend Of ¥12.00
Jul 25Nipro (TSE:8086) Will Pay A Dividend Of ¥12.00
Jul 11Nipro (TSE:8086) Has A Somewhat Strained Balance Sheet
Jun 06Earnings Tell The Story For Nipro Corporation (TSE:8086)
Apr 02Nipro (TSE:8086) Will Pay A Larger Dividend Than Last Year At ¥15.00
Feb 27CEO
Yoshihiko Sano (79 yo)
12.6yrs
Tenure
Mr. Yoshihiko Sano serves as President since May 2012 and Representative Director of Nipro Corporation. Mr. Sano served as Managing Director of Nipro Corporation since June 2006 until May 2012. He is Chair...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Chairman of Board & President | 12.6yrs | no data | 0.068% ¥ 162.0m | |
| Manager of Accounting Department - Corporate Planning Division | 10.4yrs | no data | no data | |
| GM of General Affairs | 10.4yrs | no data | 0.015% ¥ 36.8m | |
| Senior MD | 12.5yrs | no data | 0.0061% ¥ 14.6m | |
| MD, Head of Planning and Development and Director | 9.5yrs | no data | 0.0084% ¥ 20.1m | |
| Senior MD | 9.9yrs | no data | 0.011% ¥ 26.7m | |
| MD, Head of Regenerative Medicine and Business Promotion | 9.5yrs | no data | 0.018% ¥ 42.9m | |
| MD, GM of Facilities Division & Production Technology Center and Director | 10.7yrs | no data | 0.011% ¥ 25.8m | |
| MD, Head of Pharmaceutical Business Division and Pharmaceutical Production & Director | 12.2yrs | no data | 0.0037% ¥ 8.9m | |
| MD, GM of the Stable Production & Crisis Management Division and Director | 10.7yrs | no data | 0.013% ¥ 29.9m | |
| Director of Quality Assurance Division & Director | 13.7yrs | no data | 0.0094% ¥ 22.4m | |
| MD, Head of Vascular Business Division & Director | no data | no data | 0.012% ¥ 29.1m |
10.7yrs
Average Tenure
66yo
Average Age
Experienced Management: 8086's management team is seasoned and experienced (10.7 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Chairman of Board & President | 31.8yrs | no data | 0.068% ¥ 162.0m | |
| GM of General Affairs | 15.5yrs | no data | 0.015% ¥ 36.8m | |
| Senior MD | 18.5yrs | no data | 0.0061% ¥ 14.6m | |
| MD, Head of Planning and Development and Director | no data | no data | 0.0084% ¥ 20.1m | |
| Senior MD | no data | no data | 0.011% ¥ 26.7m | |
| MD, Head of Regenerative Medicine and Business Promotion | 15.5yrs | no data | 0.018% ¥ 42.9m | |
| MD, GM of Facilities Division & Production Technology Center and Director | 14.5yrs | no data | 0.011% ¥ 25.8m | |
| MD, Head of Pharmaceutical Business Division and Pharmaceutical Production & Director | no data | no data | 0.0037% ¥ 8.9m | |
| MD, GM of the Stable Production & Crisis Management Division and Director | no data | no data | 0.013% ¥ 29.9m | |
| Director of Quality Assurance Division & Director | 14.5yrs | no data | 0.0094% ¥ 22.4m | |
| MD, Head of Vascular Business Division & Director | no data | no data | 0.012% ¥ 29.1m | |
| Senior MD | 18.3yrs | no data | 0.0043% ¥ 10.3m |
15.5yrs
Average Tenure
64yo
Average Age
Experienced Board: 8086's board of directors are seasoned and experienced ( 15.5 years average tenure).
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/22 01:08 |
| End of Day Share Price | 2024/12/20 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2024/03/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Nipro Corporation is covered by 12 analysts. 4 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Masahiro Nakanomyo | Barclays |
| Craig Nelson | BNP Paribas Securities (Asia) |
| Yuki Yamazaki | Daiwa Securities Co. Ltd. |